SymBiosis Capital Management
Overview
SymBiosis Capital Management is a venture capital investment firm based in Bentonville, Arkansas. The firm invests solely in novel therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biosplice Therapeutics | Apr 2021 | VC Round | Co-investor |
| Metsera | Nov 2024 | Series B | Co-investor |
| Fog Pharmaceuticals | Mar 2024 | Series E | Co-investor |
| Metagenomi | Jan 2023 | Series B Extension | Lead |
| Sesen | Mar 2023 | Reverse Merger | Co-investor |
For institutional investors. Book with your work email.
Key People
Chidozie Ugwumba
Founder & Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SymBiosis Capital Management based?
SymBiosis Capital Management is headquartered in Bentonville, Arkansas, United States.
When was SymBiosis Capital Management founded?
SymBiosis Capital Management was founded in 2021.
How many portfolio companies does SymBiosis Capital Management have?
SymBiosis Capital Management has 27 portfolio companies in Caplight's dataset.
What are some companies in SymBiosis Capital Management's portfolio?
Portfolio companies visible on Caplight include Biosplice Therapeutics, Metsera, Fog Pharmaceuticals, Metagenomi, Sesen.
What was SymBiosis Capital Management's most recent investment shown here?
SymBiosis Capital Management's most recent investment in this portfolio sample was in Metsera in 2024.
What sectors does SymBiosis Capital Management focus on?
SymBiosis Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does SymBiosis Capital Management focus on?
SymBiosis Capital Management typically invests at the Mid stage.
What is SymBiosis Capital Management's AUM?
SymBiosis Capital Management's assets under management are estimated between $100.0M and $250.0M.